share_log

Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts

Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts

专家预测:evolent health从7位分析师的角度看
Benzinga ·  10/08 11:00
In the latest quarter, 7 analysts provided ratings for Evolent Health (NYSE:EVH), showcasing a mix of bullish and bearish perspectives.
在最新的季度里,有7位分析师就Evolent Health (纽交所:EVH) 进行了评级,展现了看好和看淡的观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估,下表展示了过去30天内不断变化的情绪,并将其与之前的几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Evolent Health, presenting an average target of $38.29, a high estimate of $45.00, and a low estimate of $31.00. Witnessing a positive shift, the current average has risen by 4.3% from the previous average price target of $36.71.
在12个月价格目标的评估中,分析师揭示了 evolent health 的见解,提出了38.29美元的平均目标,45.00美元的高估值和31.00美元的低估值。目前的平均价格已经比上一个36.71美元的平均价格目标上升了4.3%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级:详细剖析
In examining recent analyst actions, we gain insights...
通过审查最近分析...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发